Summary
Overview
Work History
Education
Skills
Accomplishments
Certification
Languages
Affiliations
Work Availability
Timeline
a3
Sérgio Manuel Moreira Luciano

Sérgio Manuel Moreira Luciano

Lisbon

Summary

Senior executive with extensive experience in management functions as CFO and CEO. Specializes in sustainable value creation, driving development through purpose and values-based leadership. Skilled in aligning motivated and competent individuals with lean processes and efficient infrastructures to deliver high-quality, innovative, customer-oriented solutions while balancing diverse stakeholder interests. Thrives in challenging environments, excelling in strategic and operational planning with a focus on execution to consistently achieve outstanding results. Experienced in integrating small companies into larger business units, launching international business units, and developing global business. Cultivates a hands-on managerial culture rooted in entrepreneurship, partnership, rigor, discipline, knowledge sharing, and cooperation - always striving for best practices and excellence.

Overview

33
33
years of professional experience
2
2
Certification

Work History

CEO / Managing Director

Quilaban, S.A.
04.2013 - Current
  • Company Overview: Quilaban, S.A. is a Portuguese company that operates in the pharmaceutical sector through an extensive portfolio of products and services covering a wide range of areas, namely pharmaceutical distribution, diagnostics, point of care, healthcare consumables, medical and surgical services, international sourcing and logistics, training, procurement, tender supply, and consultancy. Quilaban, with a business history of almost 50 years, is part of a familiar venture and holds several companies covering different health-related business areas, including diagnostics, pharmaceutical distribution, and medical clinics. It has an international presence in India, Angola, Mozambique, Namibia, and Guinée Bissau and develops commercial activities with 14 countries in Africa, Europe, and the Far East. Driven by the purpose of Caring about People’s Health and Well-Being, it has in Partnership a core element of its vision and a fundamental driver to build its Mission—promoting Healthcare. The focus on the Client and People is the basis for building unique value propositions, constantly integrating its core values: Service, Quality, Trust, Partnership, Simplicity, and Innovation. Directly and indirectly, through related companies, Quilaban generates a global turnover of over €40m, through the dedicated work of 260 people.
  • Chief Executive Officer
  • Achieved company growth by implementing strategic plans and streamlining operations.
  • President of the Executive Board of Directors
  • Managed partnerships and strategic business relationships by negotiating contract terms and handling conflicts.
  • President of the Board of Directors of associated companies in India, Guinée Bissau, Angola, and Mozambique.
  • Developed key operational initiatives to drive and maintain substantial business growth.
  • Creation of a broad portfolio of successful partnerships with leading multinational companies in diagnostics, genetic sequencing, medicines, and healthcare devices.
  • Enhanced brand reputation with effective marketing campaigns and public relations efforts.
  • Successful business transformation, integrating new businesses with innovative value propositions, reaching a combined annual growth above 10%, and replacing non-sustainable businesses.
  • Created a positive work culture, resulting in increased employee satisfaction and retention rates.
  • Customer and supplier satisfaction index above 95%
  • Established new revenue streams by identifying market opportunities and launching innovative products or services.
  • Best Place to Work certification.
  • Fostered strong relationships with industry partners to expand business opportunities.
  • #1 in the 2024 People Engagement Survey in the sector of Health and Pharmaceutical
  • Top 20 Happiness Works Company.
  • Ensured regulatory compliance by developing robust policies, procedures, and internal controls.
  • PME Líder 2024
  • Creation of a highly differentiated team covering several areas of specialization in human health.
  • Implementation of a new governance system to sustain the transition from a familiar to a professional management model, preserving cultural traits, group core values, and identity.
  • Construction of an international business network, made by associated companies in India, Mozambique, Angola, Guinée Bissau, and partnerships for business development covering more than 20 countries.
  • Committed to Sustainable Development Goals, through participation in the United Nations Global Compact Portugal.
  • Successful certification under ISO 9001 and ISO 14001. ISO 45001 in progress.
  • Implementation of a standard management model for Quilaban and related companies sustained by a Strategic and Operational Plan and a balanced scorecard model to follow up on execution and align the organization.
  • Rebranding Quilaban and creating a Group Brand – Augma Group - launching a new communication strategy through the company website, annual report, and several internal and external communication instruments.
  • Full transparency on the relationship with principal shareholders is also evident in the publication of an annual integrated report, which has presented a triple bottom-line performance since 2024.
  • Secured financing for critical projects through negotiation of favorable loan terms with financial institutions or investors.
  • Cultivated forward-thinking, inclusive, and performance-oriented business culture to lead industry in innovation and push progress.
  • Led successful turnaround efforts for underperforming divisions or subsidiaries, restoring profitability within tight timeframes.
  • Secured advantageous partnerships and collaborations to co-develop cutting-edge technologies and solutions.
  • Nurtured key strategic partnerships that resulted in enhanced product offerings and expanded customer base.
  • Bolstered employee engagement and reduced turnover by introducing progressive workplace policies and benefits.
  • Fostered culture of continuous improvement, encouraging innovation and rewarding exceptional performance.
  • Founded performance- and merit-based evaluation system to assess staff performance.
  • Cultivated a strong organizational culture built on integrity accountability teamwork which resulted in higher retention rates among staff.
  • Promoted a culture of continuous learning by investing in employee development programs and resources.
  • Revitalized company's online presence, launching user-friendly website and engaging social media platforms.
  • Led negotiation of landmark deal, establishing company as key player in new market segment.
  • Implemented innovative programs to increase employee loyalty and reduce turnover.

Deputy General Coordinator at National Association of Pharmacies, Member of the Executive Board, Managing Director of ProFarmácia

Associação Nacional das Farmácias
03.2012 - 03.2013
  • Company Overview: Associação Nacional das Farmácias (ANF) represents and supports 97% of the 2,800 pharmacies operating in Portugal. Develops various professional services and solutions to support associated pharmacies and holds multiple investments in companies operating in health-related areas, namely IT services and solutions, pharmaceutical distribution, market information, and pharmaceutical studies. With an annual turnover of €300M, ANF Group employs 700 people.
  • Support the General Coordinator in the global management of ANF’s structure.
  • Management of accounting, tax, financial planning, control, and general services departments.
  • Management of associated companies' portfolios.
  • Launch and general management of the ProFarmácia project to support pharmacies with financial difficulties in implementing management models and recovery plans in coordination with main creditors to ensure business sustainability.
  • Management of teams, including 28 internal people and external consultants.
  • Management of investment portfolio.
  • Coordination of several processes with Portuguese and European competition authorities.
  • Development of several training initiatives to support pharmacy management.
  • Implementation of a balanced scorecard for management of ANF’s internal departments.
  • Renegotiation of the insurance portfolio for associated pharmacies, integrating a global saving of insurance premiums between 10 and 20%.
  • Restructuring of credit control processes to ensure the successful management of a €10m credit portfolio.
  • Development and implementation of a global management program for pharmacies.
  • Implement a partnership program with pharmacies’ creditors (banks and suppliers) within a restructuring program above €90m.
  • Creation of a global training program for pharmacy management.

CFO, Finance and Administrative Director, Member of the Board, Member of Alliance Healthcare International Senior Management Group from 2000 until 2006

Alliance Healthcare
09.1999 - 03.2012
  • Company Overview: With a turnover of approx. €570m and 480 people, Alliance Healthcare was the leader of pharmaceutical distribution in Portugal through a vast network of warehouses and distribution, pre-wholesaling services, and a strong partnership with Laboratories and Pharmacies. Alliance Healthcare was held in Portugal through a partnership between ANF, José de Mello Group, and Alliance Boots, a leading Group in European pharmaceutical distribution.
  • General and cost accounting; internal control; Treasury; taxes; risk management; mergers and acquisitions; planning and reporting; legal issues; governance; information technologies; credit control; international reporting; strategic planning; policies and procedures.
  • Management of a team with 49 people and external consultants.
  • Acquisition and integration of 5 companies from 2000 until 2009, representing a global investment of over €25m.
  • Negotiation of the €65m deal for selling 51% of Alliance Healthcare Portugal to ANF and José de Mello.
  • Refinance the Portuguese debt locally by €70m.
  • Implementation of the ERP SAP and the transformation of the technological infrastructure.
  • Implement a credit control system to manage more than 4,800 accounts and a total debt of over €180m.
  • Implementation of a treasury management system and automation of financial flows.
  • Develop and control a global restructuring plan involving the closure of several branches and the redundancy of circa 120 people with annual savings of over €1m in overheads.
  • Development, in coordination with the HR function of an Internal Executive MBA on business management for the management team, involving 40 people.
  • Launch of new business streams.

Group Financial Controller

Alliance UniChem
07.1997 - 09.1999
  • Company Overview: Alliance Unichem resulted from an intensive process of acquisition and integration of small pharmaceutical wholesalers since 1992 and from the merger of two crucial Groups with European presence, which led to the creation of the biggest European Group in the pharmaceutical wholesaling area. This Group was floated on the London Stock Exchange and was part of the FTSE100 index until 2006, when it became private.
  • Internal and external management reporting, internal control environment, budgeting, and planning processes.
  • Creation of a standard system to support the integration of information for the six existing companies, following the merger that occurred in 1997, working in close coordination and developing partnerships with each company’s managers.
  • Led in 1999 the legal, tax, and accounting processes for the reorganization of the Portuguese Group, in which the activities of 4 companies were concentrated in only one.

Auditor

Ernst & Young
09.1992 - 07.1997
  • Planning and execution of audit works; audit teams’ management and development.
  • Wide experience in audit of various Portuguese and International companies in several business areas, namely: - Wood, Electrical, Electronic equipment, Textile, Chemical, and Pharmaceutical distribution.

Education

MBA - Management

Católica Porto Business School
07.2004

Degree - Financial Management

Instituto Superior de Administração e Gestão
12.1995

Bachelor - Accounting and Administration

Instituto Superior De Contabilidade E Administração Do Porto
07.1992

Skills

  • Microsoft Office proficiency
  • Effective decision making
  • Customer focus
  • Strategic visioning
  • Customer-centric approach
  • Operational excellence
  • Strategic planning
  • Crisis management
  • Effective corporate governance
  • Mergers and acquisitions
  • Negotiation
  • Inspirational leadership
  • Analytical and critical thinker
  • Building strategic partnerships
  • Change and growth management
  • Regulatory compliance

Accomplishments

Achieved company growth by implementing strategic plans and streamlining operations:

· Implementation of a new governance system to sustain the transition from a familiar to a professional management model, preserving cultural traits, group core values, and identity.

· Implementation of a standard management model for Quilaban and Group companies, sustained by a Strategic, Tactical, and Operational Plan and a balanced scorecard model, to follow up on execution and align the organization.

· Led successful turnaround efforts for underperforming divisions or subsidiaries, restoring performance and profitability.

· Integration of new business streams with innovative value propositions, replacing old, non-sustainable, non-profitable businesses, reaching a combined average annual business growth above 10%.

· Construction of an international business network, made by associated companies in India, Mozambique, Angola, Guinea-Bissau, and partnerships for business development covering more than 20 countries.

Secured advantageous partnerships and collaborations to co-develop cutting-edge technologies and solutions:

· Genomics business launched in 2020, through a partnership with Illumina, reached €10M in 4 years, representing 25% of the Group's turnover, and positioned Quilaban as a leader in Genomics in the Portuguese Market.

· Trustful and transparent business relationships led to an enhanced portfolio of +40 representations

· Creation of a broad portfolio of successful partnerships with leading multinational companies in diagnostics, genetic sequencing, medicines, and healthcare devices.

· “Quilaban Academy” initiative drives the share of state-of-the-art knowledge from scientists to professionals who apply the innovations in the field.

Enhanced brand reputation with effective marketing campaigns and public relations efforts:

· Publication of an annual integrated report, presenting a triple bottom-line performance since 2024.

· Wide coverage of Quilaban's initiatives and awards on social media.

· Effective management of crisis during COVID, protecting Quilaban's reputation.

Created a positive work culture, increasing employee attraction, satisfaction, and retention rates:

· Best Place to Work certification.

· #1 in the 2024 People Engagement Survey in the sector of Health and Pharmaceutical

· Top 20 Happiness Works Company.

· “Educar para o Futuro” program, to support kids' Education, impacting +90 children.

· Implementation of the "Mood Sensor" tool to monitor people's mood and promote team' cohesion and mutual support.

Ensured compliance with regulatory and best practices by developing robust policies and procedures:

· Successful certification under ISO 9001 and ISO 14001. ISO 45001 in progress.

· Committed to Sustainable Development Goals, through participation in the United Nations Global Compact Portugal since 2020.

Founded a performance-and-merit based evaluation system to assess staff performance:

· Implementation of “Modelo de Impacto Funcional,” a tool connecting purpose to action, giving meaning to employees' actions, and measuring impact and performance.

Revitalized company's image and online presence, launching user-friendly website and engaging social media platforms:

· Rebranding Quilaban and creation of a Group Brand – Augma Group - launching a new communication strategy through the company website, annual report, and several internal and external communication instruments.

+13.000 followers in LinkedIn.

Certification

  • Peak Performance Leadership – The Kilimanjaro Experience, NOVA School of Business and Economics, 2025
  • Corporate Governance – Atuação em Boards; Nova School of Management, 2019
  • Advanced Management Program; Universidade Católica Portuguesa and Kellog School of Management, 2018
  • Executive Coaching Program – Level I; EEC, 2015
  • The Complete Skilled Negotiator; The GAP Partnership, 2008
  • The Strategic Negotiator; The GAP Partnership, 2008
  • Strategic Leadership; INSEAD, Alliance UniChem Leadership Academy, 2006
  • Chartered Accountant Training; Câmara dos Revisores Oficiais de Contas, 1997

Languages

Portuguese
Bilingual or Proficient (C2)
English
Advanced (C1)
Spanish
Elementary (A2)
French
Elementary (A2)

Affiliations

  • Member of the Certified Accountants Professional Association
  • Member FAE – Fórum de Administradores e Gestores de Empresas
  • Member of APG – Associação Portuguesa de Gestão das Pessoas

Work Availability

monday
tuesday
wednesday
thursday
friday
saturday
sunday
morning
afternoon
evening
swipe to browse

Timeline

CEO / Managing Director

Quilaban, S.A.
04.2013 - Current

Deputy General Coordinator at National Association of Pharmacies, Member of the Executive Board, Managing Director of ProFarmácia

Associação Nacional das Farmácias
03.2012 - 03.2013

CFO, Finance and Administrative Director, Member of the Board, Member of Alliance Healthcare International Senior Management Group from 2000 until 2006

Alliance Healthcare
09.1999 - 03.2012

Group Financial Controller

Alliance UniChem
07.1997 - 09.1999

Auditor

Ernst & Young
09.1992 - 07.1997

Degree - Financial Management

Instituto Superior de Administração e Gestão

Bachelor - Accounting and Administration

Instituto Superior De Contabilidade E Administração Do Porto

MBA - Management

Católica Porto Business School
Sérgio Manuel Moreira Luciano